Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
In the past decade, physicians have recommended that women undergoing some surgeries have their fallopian tubes removed at the same time to prevent ovarian cancer.
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
The program brings together physicians and nurse practitioners from multiple disciplines to provide care for smokers and ex-smokers who are at high risk for lung cancer and other complications.
Columbia geneticist Wendy Chung reflects on the progress made in cancer genetics and discusses the next frontier of using genetic information to design personalized cancer prevention strategies.
Columbia cancer researchers estimate that 60% of patients in a phase 2 clinical trial will have no sign of their cancer two years after treatment with combination therapy.
Heavy ions could radically improve radiation therapy for cancer treatment, but research is needed to understand how they work. With the aid of a new instrument at Columbia, scientists aim to find out.
Columbia's Lisa A. Kachnic, MD, a pioneer in radiation oncology, discusses the advancements made in the field of radiotherapy and the innovation to come.